Create mode – the default mode when you create a requisition and PunchOut to Bio-Rad. You can create and edit multiple shopping carts
Edit mode – allows you to edit or modify an existing requisition (prior to submitting). You will be able to modify only the cart that you have PunchedOut to, and won't have access to any other carts
Inspect mode – when you PunchOut to Bio-Rad from a previously created requisition but without initiating an Edit session, you will be in this mode. You cannot modify any Cart contents
Bio-Rad-Antibodies.com relies on third-party cookies to show you pricing, allow you to order online, and connect you to My Bio-Rad. Please amend your browser settings to enable third-party cookies and access this website’s full functionality.
Click here to find out how
Unprimed T Cell Activation - Pharmacologic Methods
This method provides a general procedure for activating T cells prior to staining for intracellular cytokines, activation markers or cell proliferation using pharmacologic means. These include agents such as PMA and ionomycin, PHA and Con A. All blood samples must be collected into heparin anticoagulant as EDTA will interfere with the cell stimulation process.
This protocol is for use for use with the majority of Bio-Rad reagents. In some cases specific recommendations are provided on product datasheets, and these methods should always be used in conjunction with the product and batch specific information provided with each vial. A certain level of technical skill and immunological knowledge is required for the successful design and implementation of these techniques; these are guidelines only and may need to be adjusted for particular applications.
Mode of Action
Cell Stimulation Reagent (with Brefeldin A) BUF077A
Human, mouse, rat
Mixture of PMA, ionomycin and Brefeldin A. Brefeldin A is a protein transport inhibitor that leads to an accumulation of cytokines in intracellular space
Phorbol 12-myristate 13-acetate (PMA)
Activation of protein kinase C, use with ionomycin
Calcium ionophore, use with PMA
Indirect TCR cross-linking, requires antigen presenting cells
Concanavalin A (Con A)
1. Isolate PBMC using the appropriate methods, for example, for human peripheral blood refer to protocol FC2 Preparation of Human Peripheral Blood Mononuclear Cells, for mouse and rat spleen refer to protocol FC3 Preparation of Peritoneal Macrophages, Bone Marrow, Thymus and Spleen Cells.
2. Resuspend in the appropriate media and adjust to 1 x 106 cells/ml.
For proliferation studies using CytoTrack™ Cell Proliferation Assay or CFSE, incubate cells with the dye following the recommended protocol, or see protocol FC18 Measuring Cell Proliferation Using Cell Permeable Dyes.
3. Add the pharmacological agent to each well. See Table 1 for list of reagents and final concentrations. This will differ depending on the species and origins of your cells and the experimental requirements. Add an equivalent amount of PBS or media to a tube to act as an unstimulated control.
4. Add 1 x 105 cells and incubate cells in a humidified 37oC, 5% CO2 incubator for 6–72 hrs depending on experimental needs.
5. Harvest cells and perform surface or intracellular staining as required. Note: cytokine staining requires golgi inhibitors such as brefeldin A and monensin, see Cell Stimulation Reagent (with Brefeldin A) (BUF077A) or protocol FC9 Direct Immunofluoresence Staining of Intracellular Cytokines in Blood for more details.
6. Acquire by flow cytometry.
Appropriate controls should be carried out for flow cytometry, consider including the following: